A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
Clinical trial NCT07405801 · RECRUITING
Trial details
- NCT number
- NCT07405801
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-07
- Primary completion
- 2028-12-19
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.